Late-onset and long-lasting immune-related adverse events from immune checkpoint-inhibitors: An overlooked aspect in immunotherapy
2021 · European Journal of Cancer · 180 citations
https://doi.org/10.1016/j.ejca.2021.03.010
E
Eleonora Ghisoni
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
93
Papers
2.1K
Citations
22
h-index
31
i10-index
Eleonora Ghisoni is an academic researcher from University Hospital of Lausanne. The author has contributed to research in topics: Cancer Immunotherapy and Biomarkers & Ovarian cancer diagnosis and treatment & Immunotherapy and Immune Responses. The author has an h-index of 22, co-authored 80 publications.
ORCID: 0000-0003-1950-0315Papers by this author
worksPGE2 inhibits TIL expansion by disrupting IL-2 signalling and mitochondrial function
2024 · Nature · 174 citations
https://doi.org/10.1038/s41586-024-07352-w
Androgen receptor status predicts development of brain metastases in ovarian cancers
2017 · Oncotarget · 23 citations
https://doi.org/10.18632/oncotarget.17068
Validation of Androgen Receptor loss as a risk factor for the development of brain metastases from ovarian cancers
2020 · Journal of Ovarian Research · 10 citations
https://doi.org/10.1186/s13048-020-00655-2
Tumor-reactive clonotype dynamics underlying clinical response to TIL therapy in melanoma
2023 · bioRxiv (Cold Spring Harbor Laboratory) · 8 citations
https://doi.org/10.1101/2023.07.21.544585
3153P Health-related quality of life assessment and results in clinical trials testing new cancer drugs approved by the European Medicines Agency (EMA) between 2019 and 2024
2025 · Annals of Oncology · 0 citations
https://doi.org/10.1016/j.annonc.2025.08.1625
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat